Early Secreted Antigen ESAT-6 of Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner

English version České info

Despite its relatively poor efficacy, Bacillus Calmette-Guérin (BCG) has been used as a tuberculosis (TB) vaccine since its development in 1921. BCG induces robust T helper 1 (Th1) immune responses but, for many individuals, this is not sufficient for host resistance against Mycobacterium tuberculosis (M. tb) infection. Here we provide evidence that early secreted antigenic target protein 6 (ESAT-6), expressed by the virulent M. tb strain H37Rv but not by BCG, promotes vaccine-enhancing Th17 cell responses. These activities of ESAT-6 were dependent on TLR-2/MyD88 signalling and involved IL-6 and TGF-β production by dendritic cells. Thus, animals that were previously infected with H37Rv or recombinant BCG containing the RD1 region (BCG::RD1) exhibited improved protection upon re-challenge with virulent H37Rv compared with mice previously infected with BCG or RD1-deficient H37Rv (H37RvΔRD1). However, TLR-2 knockout (TLR-2^-/-) animals neither showed Th17 responses nor exhibited improved protection in response to immunization with H37Rv. Furthermore, H37Rv and BCG::RD1 infection had little effect on the expression of the anti-inflammatory microRNA-146a (miR146a) in dendritic cells (DCs), whereas BCG and H37RvΔRD1 profoundly induced its expression in DCs. Consistent with these findings, ESAT-6 had no effect on miR146a expression in uninfected DCs, but dramatically inhibited its upregulation in BCG-infected or LPS-treated DCs. Collectively, our findings indicate that, in addition to Th1 immunity induced by BCG, RD1/ESAT-6-induced Th17 immune responses are essential for optimal vaccine efficacy.

Vyšlo v časopise: Early Secreted Antigen ESAT-6 of Promotes Protective T Helper 17 Cell Responses in a Toll-Like Receptor-2-dependent Manner. PLoS Pathog 7(11): e32767. doi:10.1371/journal.ppat.1002378
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002378

Souhrn

Zdroje

1. GuptaUDKatochVMMcMurrayDN 2007 Current status of TB vaccines. Vaccine 25 3742 3751

2. ColditzGABrewerTFBerkeyCSWilsonMEBurdickE 1994 Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271 698 702

3. BrewerTF 2000 Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 31 Suppl 3 S64 67

4. FinePE 1989 The BCG story: lessons from the past and implications for the future. Rev Infect Dis 11 Suppl 2 S353 359

5. FinePE 1995 Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346 1339 1345

6. BrodinPRosenkrandsIAndersenPColeSTBroschR 2004 ESAT-6 proteins: protective antigens and virulence factors? Trends Microbiol 12 500 508

7. SimeoneRBottaiDBroschR 2009 ESX/type VII secretion systems and their role in host-pathogen interaction. Curr Opin Microbiol 12 4 10

8. BrandtLOettingerTHolmAAndersenABAndersenP 1996 Key epitopes on the ESAT-6 antigen recognized in mice during the recall of protective immunity to Mycobacterium tuberculosis. J Immunol 157 3527 3533

9. RavnPDemissieAEgualeTWondwossonHLeinD 1999 Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis. J Infect Dis 179 637 645

10. UlrichsTMunkMEMollenkopfHBehr-PerstSColangeliR 1998 Differential T cell responses to Mycobacterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol 28 3949 3958

11. DietrichJWeldinghKAndersenP 2006 Prospects for a novel vaccine against tuberculosis. Vet Microbiol 112 163 169

12. GallegosAMPamerEGGlickmanMS 2008 Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J Exp Med 205 2359 2368

13. PymASBrodinPMajlessiLBroschRDemangelC 2003 Recombinant BCG exporting ESAT-6 confers enhanced protection against tuberculosis. Nat Med 9 533 539

14. LewisKNLiaoRGuinnKMHickeyMJSmithS 2003 Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guerin attenuation. J Infect Dis 187 117 123

15. PereraPYDerrickSCKolibabKMomoiFYamamotoM 2009 A multi-valent vaccinia virus-based tuberculosis vaccine molecularly adjuvanted with interleukin-15 induces robust immune responses in mice. Vaccine 27 2121 2127

16. KhaderSABellGKPearlJEFountainJJRangel-MorenoJ 2007 IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge. Nat Immunol 8 369 377

17. KhaderSACooperAM 2008 IL-23 and IL-17 in tuberculosis. Cytokine 41 79 83

18. BettelliECarrierYGaoWKornTStromTB 2006 Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441 235 238

19. ManganPRHarringtonLEO'QuinnDBHelmsWSBullardDC 2006 Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441 231 234

20. StarczynowskiDTKuchenbauerFArgiropoulosBSungSMorinR 2010 Identification of miR-145 and miR-146a as mediators of the 5q- syndrome phenotype. Nat Med 16 49 58

21. TaganovKDBoldinMPChangKJBaltimoreD 2006 NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A 103 12481 12486

22. NahidMAPauleyKMSatohMChanEK 2009 miR-146a is critical for endotoxin-induced tolerance: IMPLICATION IN INNATE IMMUNITY. J Biol Chem 284 34590 34599

23. LiuZXiaoBTangBLiBLiN 2010 Up-regulated microRNA-146a negatively modulate Helicobacter pylori-induced inflammatory response in human gastric epithelial cells. Microbes Infect 12 854 863

24. LuLFListonA 2009 MicroRNA in the immune system, microRNA as an immune system. Immunology 127 291 298

25. FlynnJLChanJTrieboldKJDaltonDKStewartTA 1993 An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 178 2249 2254

26. GlickmanMSJacobsWRJr 2001 Microbial pathogenesis of Mycobacterium tuberculosis: dawn of a discipline. Cell 104 477 485

27. Goter-RobinsonCDerrickSCYangALJeonBYMorrisSL 2006 Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses. Vaccine 24 3522 3529

28. KellyBPFurneySKJessenMTOrmeIM 1996 Low-dose aerosol infection model for testing drugs for efficacy against Mycobacterium tuberculosis. Antimicrob Agents Chemother 40 2809 2812

29. UmemuraMYahagiAHamadaSBegumMDWatanabeH 2007 IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 178 3786 3796

30. CruzAFragaAGFountainJJRangel-MorenoJTorradoE 2010 Pathological role of interleukin 17 in mice subjected to repeated BCG vaccination after infection with Mycobacterium tuberculosis. J Exp Med 207 1609 1616

31. GangulyNSiddiquiISharmaP 2008 Role of M. tuberculosis RD1 region encoded secretory proteins in protective response and virulence. Tuberculosis (Edinb) 88 510 517

32. GuinnKMHickeyMJMathurSKZakelKLGrotzkeJE 2004 Individual RD1-region genes are required for export of ESAT-6/CFP-10 and for virulence of Mycobacterium tuberculosis. Mol Microbiol 51 359 370

33. PymASBrodinPBroschRHuerreMColeST 2002 Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti. Mol Microbiol 46 709 717

34. JungYJRyanLLaCourseRNorthRJ 2005 Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice. J Exp Med 201 1915 1924

35. KamathABBeharSM 2005 Anamnestic responses of mice following Mycobacterium tuberculosis infection. Infect Immun 73 6110 6118

36. ZengGChenCYHuangDYaoSWangRC 2011 Membrane-bound IL-22 after de novo production in tuberculosis and anti-Mycobacterium tuberculosis effector function of IL-22+ CD4+ T cells. J Immunol 187 190 199

37. AagaardCDietrichJDohertyMAndersenP 2009 TB vaccines: current status and future perspectives. Immunol Cell Biol 87 279 286

38. PathakSKBasuSBasuKKBanerjeeAPathakS 2007 Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages. Nat Immunol 8 610 618

39. SrivastavaVManchandaMGuptaSSinglaRBeheraD 2009 Toll-like receptor 2 and DC-SIGNR1 differentially regulate suppressors of cytokine signaling 1 in dendritic cells during Mycobacterium tuberculosis infection. J Biol Chem 284 25532 25541

40. Teixeira-CoelhoMCruzACarmonaJSousaCRamos-PereiraD 2011 TLR2 deficiency by compromising p19 (IL-23) expression limits Th 17 cell responses to Mycobacterium tuberculosis. Int Immunol 23 89 96

41. OttenhoffTHKumararatneDCasanovaJL 1998 Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria. Immunol Today 19 491 494

42. CooperAMDaltonDKStewartTAGriffinJPRussellDG 1993 Disseminated tuberculosis in interferon gamma gene-disrupted mice. J Exp Med 178 2243 2247

43. CooperAMKhaderSA 2008 The role of cytokines in the initiation, expansion, and control of cellular immunity to tuberculosis. Immunol Rev 226 191 204

44. MajlessiLSimsovaMJarvisZBrodinPRojasMJ 2006 An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis. Infect Immun 74 2128 2137

45. BhattacharyyaSSinglaRDeyABPrasadHK 1999 Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis. Infect Immun 67 5597 5603

46. LealISSmedegardBAndersenPAppelbergR 2001 Failure to induce enhanced protection against tuberculosis by increasing T-cell-dependent interferon-gamma generation. Immunology 104 157 161

47. LagranderieMAbolhassaniMVanoirbeekJALimaCBalazucAM 2010 Mycobacterium bovis bacillus Calmette-Guerin killed by extended freeze-drying targets plasmacytoid dendritic cells to regulate lung inflammation. J Immunol 184 1062 1070

48. LeeJReinkeEKZozulyaALSandorMFabryZ 2008 Mycobacterium bovis bacille Calmette-Guerin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner. J Immunol 181 6201 6212

49. ItoTSchallerMHogaboamCMStandifordTJSandorM 2009 TLR9 regulates the mycobacteria-elicited pulmonary granulomatous immune response in mice through DC-derived Notch ligand delta-like 4. J Clin Invest 119 33 46

50. FlynnJLChanJ 2003 Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr Opin Immunol 15 450 455

51. RaghuvanshiSSharmaPSinghSVan KaerLDasG 2010 Mycobacterium tuberculosis evades host immunity by recruiting mesenchymal stem cells. Proc Natl Acad Sci U S A 107 21653 8

52. GangulyNGiangPHGuptaCBasuSKSiddiquiI 2008 Mycobacterium tuberculosis secretory proteins CFP-10, ESAT-6 and the CFP10:ESAT6 complex inhibit lipopolysaccharide-induced NF-kappaB transactivation by downregulation of reactive oxidative species (ROS) production. Immunol Cell Biol 86 98 106

53. TousifSSinghYPrasadDVSharmaPVan KaerL 2011 T cells from Programmed Death-1 deficient mice respond poorly to Mycobacterium tuberculosis infection. PLoS One 6 e19864

54. DevadasSDasJLiuCZhangLRobertsAI 2006 Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells. Immunity 25 237 247